VAERS reports by lot

Moderna COVID-19 lot 062G20A: VAERS reports

116 VAERS reports list lot 062G20A as a Moderna COVID-19 vaccine, received between 2021-01-25 and 2022-09-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
116
Reports
8%
Marked serious
2
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8819%
Injection-site / Local reaction8017%
Neurological6013%
Cardiac / Cardiovascular5612%
Musculoskeletal5512%
Dermatological (non-injection-site)388%
Gastrointestinal378%
Respiratory153%
Allergic / Anaphylactic143%
Thrombotic / Hematological72%
Reproductive / Menstrual51%
Autoimmune / Immune-mediated41%
Psychiatric / Neuropsychiatric31%

Where reports came from

U.S. state of the reporter, where given (top 9).

California65
Oregon25
Mississippi14
Arizona4
North Carolina3
Texas1
Tennessee1
Washington1
Iowa1

Reports by month received

2021-017
2021-0241
2021-038
2021-041
2021-053
2021-065
2021-074
2021-0824
2021-0912
2021-103
2021-111
2021-122
2022-021
2022-032
2022-051
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.